PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Go back to PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
(NASDAQ: PRCT) Delayed: 19.30 -0.17 (0.87%)
Previous Close $19.47    52 Week High
Open $19.42    52 Week Low
Day High $19.51    P/E N/A 
Day Low $18.99    EPS
Volume 1,491,271